Cytotoxic action of carboxyborane heterocyclic amine adducts

Metal-Based Drugs

Volumn 4, Issue 4, 1997, Pages 229-241

  Miller III, Merrill C ^a   Sood, Anup ^b   Spielvogel, Bernard F ^b   Bastow, Ken ^a   Hall, Iris H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Boron Biologicals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORANE DERIVATIVE; CARBOXYBORANE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; HETEROCYCLIC AMINE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SUSPENSION; CONTROLLED STUDY; CYTOTOXICITY; DNA PROTEIN COMPLEX; DNA STRAND BREAKAGE; DNA SYNTHESIS INHIBITION; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN;

EID: 0030929169     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1997.229     Document Type: Article

References (15)

1. C.K. Sood, A. Sood, B.F. Spievogel, J.A. Yousef, B.S. Burnham, and I.H. Hall, J. Pharm. Sci. 80, 1133,(1991).
2. R.J. Geran, N.H. Greenburg, M.M. MacDonald, A.M. Schumacher and B.J. Abbott, Cancer Chemo. Rep. 3, 9, (1972).
3. L.L. Liao, S.M. Kupchan, S.B. Horwitz, Mol. Pharmacol. 12, 167, (1976).
4. H. Suzuki, T. Nishimura, S.K. Muto and N. Tanaka, J. Antibacteriol. 32, 875 (1978).
5. J.F. Pera, Sr, C.J. Rawlings, J. Shackleton and J.J. Roberts, Biochem. Biophy. Acta 655, 152 (1981).
6. J.W. Woynarowski, T.A. Beerman and J. Konopa, Biochem. Pharmacol. 30, 3005 (1981).
7. L.F. Liu, T.C. Rowe, L. Yang, K.M. Tewey and G.L.Chen, J. Biol. Chem. 258, 15365 (1983).
8. G. Miller, L.F. Liu, and P.T. England, J. Biol. Chem. 256, 9334-9339, (1981).
9. T.C. Rowe, G.L. Chen, Y.H. Hsiang and L.F. Liu, Cancer Res. 46, 2021 (1986).
10. W.G. Harker, D.L. Slade, F.H. Drake, and R.L. Parr, Biochemistry 30, 9953, 1991.
11. M. Chu and G.A. Fischer, Biochem. Pharm. 17, 753-767, (1968).
12. R.F. DeVore, A.H. Corbett andN. Osheroff, Cancer Res. 52, 2156, (1992).
13. M.R. Feng, M. Liebert, G. Wedermeyer, H.B. Grossman, W.R. Manicini, M. Williams, J.G. Wager, Selective Cancer Therapeutics 7, 75, 1991.
14. P. Ackerman, C.V. C. Glover, and N. Osheroff, Proc. National Acad Sci. 82, 3164(1985).
15. R.Bertrand, D. Kerrigan, M. Srang, and Y. Pommier, Biochem. Pharmacol. 42, 77,(1991).